Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System

• 收藏
• 分享

专利权人:

CANADIAN BLOOD SERVICES

发明人:

Mark D. Scott,Duncheng Wang,Wendy M. Toyofuku

申请号：

US16742124

公开号：

US20200147133A1

申请日:

2020.01.14

申请国别(地区):

US

年份:

2020

代理人:

摘要：

This disclosure relates to acellular-based therapies for modulating the level of regulatory T cells (Treg) and/or the level of pro-inflammatory T cells (Th17/Th1). To provide these therapeutic effects, a combination comprising at least one acellular pro-tolerogenic preparation and at least one acellular pro-inflammatory preparation are administered sequentially.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/